Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis.
Articles on Ovarian cancer
Displaying 1 - 20 of 40 articles
Monoclonal antibody drugs like Keytruda attack cancer cells in a different way to chemotherapy drugs.
Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
Women can go into menopause after cancer treatment or surgery. The timing and severity of symptoms can differ from natural menopause.
A new approach could allow even the most aggressive forms of ovarian cancer to be detected in their early stages.
Some states, especially in the Southeastern US, have large disparities in breastfeeding among racial groups, making clear the need to lower barriers for breastfeeding in the workplace and elsewhere.
The ‘egg timer’ blood test is marketed as an empowering way to give women insights to help them plan when to have children. Problem is, it can’t deliver what it promises.
Kath O'Connor’s debut novel, Inheritance, follows two women – an IVF hopeful and her grandmother – who carry the BRCA1 gene and contract ovarian cancer. It’s very close to being memoir.
There are currently no effective tests to screen for ovarian cancer. But that doesn’t mean there aren’t ways to recognize and prevent it.
I was motivated to improve the outcome for women with ovarian cancer by my experience as a junior doctor in London in 1985. But 36 years on, the results aren’t what we’d hoped.
Regular testing can mean potentially fatal diseases can be picked up and treated early.
We need to change diagnosis of ovarian cancer from late stage to early - scientists make steps
Having children is linked to a greater risk of heart attacks and stroke, but kids aren’t completely bad for your health.
A urine test for ovarian cancer could increase survival rates from 20% to 90%.
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
There are currently few effective and non-invasive methods to screen for early stages of cancer. But scientists have now developed a new blood test that promises to detect eight different cancers.
Something exciting is going on – no thanks to the supplements industry.
Scientists are making the terrifying useful.
Some studies have found a link between the long-term use of talcum powder as a feminine hygiene product and an increased risk of ovarian cancer.
The rate of Australians dying from cancer is on a steady, downhill trajectory, thanks to powerful advances made in prevention, diagnosis and treatment of the disease.
Top contributors
-
Clinical Professorial Research Fellow, Australian Women and Girls' Health Research Centre, The University of Queensland
-
Medical Oncologist and Laboratory Head, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Consultant Senior Lecturer in Clinical Genetics, UCL
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, Adelaide University
-
Professor and Cancer Theme Leader, South Australian Health & Medical Research Institute
-
Reader in Biomedical Sciences, University of Hull
-
Professor of Biochemistry, University of Aberdeen
-
PhD student in Biology, University of Rochester
-
Senior Manager, Descriptive Epidemiology, Cancer Council Queensland
-
Professor of Interdisciplinary Parasitology, University of Nottingham
-
Lab Head, Gynaecological Cancer Research Group, Lowy Cancer Rearch Centre, UNSW
-
Professor of Macromolecular Structure and Function, Imperial College London
-
Senior Lecturer and Consultant in Gynaecological Oncology, Imperial College London
-
Professor of Oncology, Head of the RMH Familial Cancer Centre and Joint Head, Breast Cancer Laboratory, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Professor of Genome Sciences, University of Washington